Stek advises Abacus on its acquisition of Pluripharm

Danish pharmaceutical supplier Abacus Medicine A/S has acquired Dutch pharmaceutical wholesaler Pluripharm Group. The group is one of four leading pharmaceutical wholesalers in the Netherlands with a full line of medicines, medical devices and services. Stek advised on the acquisition including the merger control proceeding before the Dutch Competition Authority.

Please click here for the press release.

This might also interest you

Stek represents Global Food Group in the ACM investigation into an alleged purchasing cartel

Stek advises SolarWorks! and its lead investors EDP and Persistent on a successful recapitalization

Stek victorious for KNVB in dispute about the FIFA Football Agent Regulations